Capital Access’ Post

View organization page for Capital Access, graphic

957 followers

We're excited to announce that we have today initiated coverage 🔍 📖 on The Craneware Group (#CRW). Craneware is the market leader in value cycle SaaS provision in the US with a 40% market penetration and the ambition to become ubiquitous in US hospitals. The shackles of Covid disruption, digestion of the Sentry acquisition, and the transitioning of its customers to the fully cloud based Trisus platform, have fallen away and opened up new sales opportunities for the group. While the shares have out-performed strongly, multiples look reasonable compared with peers. We calculate a DCF based fair value of 2,541p, 15% above the current share price which could easily prove conservative on stronger medium term revenue growth. Craneware sits in the sweet spot of the structural transformation underway in the US healthcare market to value-based care which is currently also the hottest area of healthcare SaaS M&A activity. If you'd like to learn more about Craneware's story, you can find the note, for free, on the portal on our website, as well as across all the usual platforms such as Bloomberg, Refinitiv, FactSet, Research Tree, etc. below. https://lnkd.in/e9HYn94d Thanks to Colin Smith for the insight, time, and effort! #research #equityresearch #equities #investmentmanagement #capitalmarkets #software #healthcare

Craneware Initiation: In the sweetspot

Craneware Initiation: In the sweetspot

capitalaccessgroup.co.uk

To view or add a comment, sign in

Explore topics